alexa BMPR-IB Reduces The Malignancy Of Glioblastoma Cells By Upregulation Of P21 And P27Kip1
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Shuang Liu, Feng Yin, Jianning Zhang, Wenhong Fan and Ming Fan
Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.030
Abstract
In the present study, we detected decreased expression of phospho-Smad1/5/8 and its upstream signaling molecule, bone morphogenetic protein receptor IB subunit (BMPR-IB), in certain glioblastoma cell lines compared to normal astrocytes. Forced BMPR-IB expression in malignant human glioma cells, which exhibit lower expression of BMPR-IB, induced the phosphorylation and nuclear localization of smad1/5/8 and arrested the cell cycle in G1. Additionally, colony formation analysis and immunofluorescence showed that BMPR-IB overexpression could suppress anchorage-independent growth and promote differentiation of theses glioblastoma cells. We also observed significant accumulation of p21 and p27kip1 proteins in response to BMPR-IB overexpression, whereas the expression level of Skp2 protein decreased during this growth arrest and differentiation process. The results were consistent with real-time RT-PCR data. Furthermore, overexpression of BMPR-IB also inhibited the growth of subcutaneous and intracranial tumor xenografts and prolonged the survival of mice injected intracranially with BMPR-IB-overexpressing glioblastoma cells. Conversely, inhibition of BMPR-IB caused SF763 malignant glioma cells, a line known to exhibit high BMPR-IB expression that does not form tumors when used for xenografts, to show increased growth and regain tumorigenicity in a nude mouse model system, ultimately shortening the survival of these mice. Our results suggest that decreased expression of BMPR-IB in most human glioblastoma cells contributes to glioma tumorigenicity and that overexpression of BMPR-IB may induce growth arrest and differentiation of glioblastoma cells due to upregulation of p21 and p27kip1 in vitro and in vivo . BMPR-IB could represent a new potential therapeutic target for malignant human gliomas.
Biography
Shuang Liu has studied molecular biology and molecular therapeutics of brain tumor and stem cells for 10+ years, during which time she has been in charge many research projects about glioma and cancer stem cells, including two Chinese National Science Foundation (No: 30873029 and No: 81172384). She authored more than 20 peer-reviewed reports. Dr. Shuang is a member of the Chinese Neuroscience Society, and has served on the editorial boards for Chinese Journal of Integrated Traditional and Western Medicine for about 10 years.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords